Charles A. Reinhart III - 04 Jun 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Financial Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
04 Jun 2021
Net transactions value
-$161,626
Form type
4
Filing time
08 Jun 2021, 16:17:29 UTC
Next filing
11 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale $161,626 -2,648 -9.6% $61.04 24,799 04 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.